Sotagliflozin found to protect kidney and heart in patients with type 2 diabetes and chronic kidney disease
Sodium-glucose cotransporter-2 (SGLT2) inhibitors, which are medications that lower blood sugar levels among other effects, provide kidney- and heart-related benefits to patients with and without diabetes. An exploratory ...
Nov 3, 2023
0
4